A Structured Blood Conservation Program in Pediatric Cardiac Surgery by Budak, A et al.
Touro Scholar 
NYMC Faculty Publications Faculty 
3-1-2017 




New York Medical College 
S Gunaydin 
Follow this and additional works at: https://touroscholar.touro.edu/nymc_fac_pubs 
 Part of the Cardiology Commons, Pediatrics Commons, and the Surgery Commons 
Recommended Citation 
Budak, A., McCusker, K., & Gunaydin, S. (2017). A Structured Blood Conservation Program in Pediatric 
Cardiac Surgery. European Review for Medical and Pharmacological Sciences, 21 (5), 1074-1079. 
Retrieved from https://touroscholar.touro.edu/nymc_fac_pubs/802 
This Article is brought to you for free and open access by the Faculty at Touro Scholar. It has been accepted for 
inclusion in NYMC Faculty Publications by an authorized administrator of Touro Scholar. For more information, 
please contact daloia@nymc.edu. 
1074
Introduction
Surgery for congenital heart defects in pedia-
tric patients undergoing cardiopulmonary bypass 
(CPB) has induced up to a 300% hemodilutional 
effect due to circuit prime volumes1. Condensing 
surface area and prime volume are especially 
important in neonatal patients where the volume 
from the CPB circuit can be the major determi-
nant in the patient’s metabolic response to sur-
gery2. This is due not only to the profound dif-
ference in the patient’s size with respect to the 
CPB prime volume but also from the deleterious 
effects of CPB on their immature organ function3. 
Additionally, hemodilution effect due to prime 
volume can result in multiple blood product expo-
sures, all of which have been shown to further 
increase the morbidity of CPB4,5. Thus, attempts 
to condense the circuit prime volume can result 
in a reduction of exposure to blood products6. 
Despite the recent introduction of a number of 
technical and pharmacologic blood conservation 
measures, bleeding and allogeneic transfusion 
remain persistent problems in open-heart surgi-
cal procedures.The use of blood products carries 
several risks, such as immunologic sensitization, 
anaphylactic reaction, and disease transmission. 
The underlying pathophysiology has not been de-
scribed entirely; however, there is evidence on the 
activation of inflammatory genes and cytokines 
in circulating leukocytes with transfusion of red 
blood cells7. Efforts should be made to decrease 
or completely avoid transfusions to avoid these 
negative reactions.
In an effort to reduce the negative impact of the 
CPB on the adult population outcome, the minimi-
zed systems were developed to significantly reduce 
the hemodilution of the patient and reduce the fo-
reign surface area that comes in continuous contact 
with the patient circulating blood volume. Redu-
Abstract. – OBJECTIVE: The limitation of alter-
native transfusion practices in infants increases 
the benefits of blood conservation. We analyzed 
the efficacy of a structured program to reduce 
transfusions and transfusion-associated com-
plications in cardiac surgery
PATIENTS AND METHODS: Our pediatric sur-
gery database was reviewed retrospectively, com-
paring outcomes from two different time periods, 
after the implementation of an effective blood con-
servation program beginning in March 2014. A to-
tal of 214 infants (8.1±3.4 months) who underwent 
biventricular repair utilizing CPB (Group 1 – Blood 
conservation) were studied in a 12-month period 
(March 2014-February 2015) after the implementa-
tion of the new program, and compared with 250 
infants (7.91±3.2 months) (Group 2 – Control-No 
blood conservation) of the previous 12 – month pe-
riod (March 2013-February 2014).
RESULTS: The proportion of patients trans-
fused with red blood cells was 75.2% (N=188) in 
control group and reduced by 16.4% in the study 
group (58.8% – 126 patients, p <0.01). The mean 
number of transfusions was 1.25 ± 0.5 units per 
patient in control group and decreased to 0.7 ± 
0.5 units per patient after the start of the pro-
gram (p = 0.035). Cerebral oximetry demonstrat-
ed better follow-up during the operative period 
confirming less hemodilution in Group 1. Respi-
ratory support, inotropic need and ICU stay were 
significantly better in the study group.
CONCLUSIONS: These findings, in addition to 
attendant risks and side effects of blood trans-
fusion and the rising cost of safer blood prod-
ucts, justify blood conservation in pediatric 
cardiac operations. Circuit miniaturization, ul-
trafiltration, and reduced postoperative bleed-
ing, presumably secondary to higher fibrinogen 
and other coagulation factor levels, contributed 
to this outcome. 
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cing the size of the perfusion apparatus has two 
obvious and immediate effects: firstly, a reduction 
in the contact surface area for potential blood-bio-
material contact; secondly, a reduction in priming 
volume requirement-less hemodilution with a con-
sequential reduction in perioperative hematocrit8.
This concept later targeted pediatric popula-
tion. Smaller, lower prime-volume circuits are 
now available with low line pressures and excel-
lent reliability and it is now possible to review the 
basic need for hemodilution and hypothermia9. 
There is wide variation in the prevalence of perio-
perative transfusions in cardiac surgery. The large 
differences between institutions cannot be explai-
ned just by differences in patient characteristics. 
Most likely, institutional and individual differences 
in transfusion practice, guidelines and attitudes in-
fluence the frequency and number of transfusions. 
The decision to transfuse is based on multiple 
patient factors and it is impossible to designate a 
single transfusion trigger. The high prevalence ini-
tiated a multifactorial blood conservation program 
with the intention of reducing transfusions without 
compromising patient safety10.
The aim of this retrospective study was to eva-
luate the efficacy of a structured program to redu-
ce transfusions and transfusion-associated com-
plications in pediatric cardiac surgery. 
Patients and Methods
After institutional Review Board approval 
(14/227) in tertiary pediatric cardiac centers, the 
database was reviewed retrospectively, compa-
ring outcomes from two different one-year pe-
riods with and without blood conservation stra-
tegy. 
A total of 214 infants (8.1±3.4 months) who 
underwent biventricular repair utilizing car-
diopulmonary bypass (CPB) (Group 1 – Blood 
conservation) were studied in a 12-month pe-
riod (March 2014-February 2015) after the im-
plementation of the new program, and compared 
with 250 infants (7.91±3.2 months) (Group 2 – 
Control-No blood conservation) of the previous 
12-month period (March 2013-February 2014). 
The outcome (dependent variable) was stated as 
blood transfusion. Independent variables were 
identified. None of the patients were premature. 
Exclusion criteria consisted of known coagulo-
pathy and endocarditis. The remainder of the pa-
tients who did not have the exclusion criteria was 
included in the study.
Pathologies in group 1 were: VSD repair in 88, 
cavo-pulmonary anastomosis in 46, aortic valvot-
omy in 17, arterial switch+VSD repair in 9, arterial 
switch in 44, TAPVR repair in 10 patients. Pathol-
ogies in group 2 were: VSD repair in 104, AVSD 
repair in 5, atrial septectomy+shunt in 16, cavo-pul-
monary anastomosis in 95, arterial switch+VSD re-
pair in 8, TAPVR repair in 7, AP window in 9, trun-
cus repair in 3 and Senning operation in 3 patients.
The blood conservation program was designed 
as follows:
• Education: All the staff involved in the care of 
the patients, including surgeons, anesthetists, 
residents, OR-, ICU- and ward nurses, nur-
se helpers, physiotherapists and perfusionists 
were educated about the risks and benefits of 
blood transfusions and the new transfusion 
guidelines in a 45-min lesson. The lesson was 
repeated for all new employees. 
• Guidelines: we revised our guidelines for 
transfusions based on the Society of Thora-
cic Surgeons Guidelines11. In the institutional 
guidelines, the decision to transfuse red cel-
ls perioperatively should be based on clinical 
judgment of the patient’s clinical and hemo-
dynamic status. Patients received red blood 
cell when a hematocrit level of < 20%, mixed 
venous oxygen saturation < 60% and regional 
cerebral oxygenation (rSO2) < 50%. The final 
decision to transfuse or not was always at the 
discretion of the physician responsible.
• Transfusion log: a specific transfusion log was 
added to the patient records. In this log, all 
transfusion episodes were registered together 
with time of transfusion, indication for tran-
sfusion, type of blood product, amount (units), 
patient status including blood pressure, pulse, 
mixed venous oxygenation, hematocrit levels 
and the prescribing physician.
• Reduction in IV fluid volume: we initiated a 
series of measures aimed at reducing hemodi-
lution volume. All sources and volumes of IV 
fluid were obtained from the medical record.
• CPB Circuit Design: significantly less prime 
volume via oxygenator with integrated arterial 
filter, condensed circuit, pole mounted vents, mi-
croplegia, ultrafiltration, use of cerebral oxyme-
try-rSO2, retrograde autologous priming, vacuum 
assisted venous drainage and cell salvage of the 
residual blood from the circuit without treatment
Operative Technique
As a part of the blood conservation program, 
the bypass circuit was aseptically assembled using 
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a low-prime integrated oxygenator and reservoir 
(Terumo Medical Corporation, Ann Arbor, MI, 
USA) in Group 1 and a Terumo System 1 pump 
console. All of the roller heads of the pump were 
remotely mounted to minimize tubing length and 
circuit surface area.Isothermic blood cardioplegia 
was administered directly into the aorta at the sur-
gical field using premixed syringes of a 1:4 hyper-
kalemic solution (1 part blood: 4 parts crystalloid) 
(Pharmedium, Portland, OR, USA). The static pri-
me volume for the circuit was approximately 220 
ml. The pump prime consisted of the following 
additives: 
(Total 95-110 cc): 1 mg/kg (100 unit/kg) hepa-
rin, 20 mg/kg cefamezin, 2.5 cc/kg, 20% manni-
tol, 10 mEq sodium bicarbonate, plasmalyte, red 
blood cell and fresh frozen plasma estimated at 
target hematocrit 25-30%.
As part of our previous routine, control group 
consisted of a conventional oxygenator and reser-
voir (Sorin, Arvada, CO, USA) that has a static 
priming volume of 350 cc.
The pump prime for control circuits consisted 
of the following additives: 
(Total 200-215 cc): 1 mg/kg (100 unit/kg) hepa-
rin, 20 mg/kg Cefamezin, 2.5 cc/kg, 20% manni-
tol, 10 mEq sodium bicarbonate, plasmalyte , red 
blood cell and fresh frozen plasma estimated at 
target hematocrit 25-30%.
Anticoagulation status was monitored using 
the Medtronic HMS+ (Medtronic, Minneapo-
lis, MN, USA) system. Samples of blood for 
measuring activated clotting times (ACT) and 
heparin concentrations were drawn every 30 
minutes on CPB. Adequate anticoagulation was 
defined as ACT greater than 500 seconds and 
heparin concentration assays greater than or 
equal to 3.0 mg/kg, as measured by the HMS+ 
device. Midazolam, sevoflurane, fentanyl and 
norcuronium were used as anesthetic agents. 
After median sternotomy, the patient was systemi-
cally anticoagulated using 339 units/kg of intra-
venous heparin. The pulse pressure was verified, 
retrograde autologous priming (RAP) was initia-
ted, and approximately 75-85 ml of crystalloid 
prime was removed. During the RAP sequence, 
venous cannulas (Edwards Lifesciences, Irvine, 
CA, USA) were placed in the superior vena cava 
and inferior vena cava, respectively. 
Vacuum-assisted venous drainage was utilized 
to allow for the use of the smaller venous cannu-
la and venous circuit. Upon initiation of bypass, 
crystalloid in the venous line was diverted into 
a collection bag and discarded. Full flow to the 
patient was achieved with no hemodynamic in-
stability within five minutes of aortic cannulation. 
CPB flow was maintained at 125-150 mL/kg/
minute. Moderate hypothermia (28-34°C) and al-
pha stat blood gas management were used.
After the repair, heart was aggressively de-ai-
red. The aortic cross-clamp was removed and 
the patient was systemically rewarmed to nor-
mothermia. A second blood gas was drawn to 
ensure proper electrolyte balance prior to termi-
nation of CPB support. The resultant hematocrit 
was around 20%. Continuous ultrafiltration was 
performed while the patient was on CPB and ap-
proximately a total of 80-90 ml of plasma water 
was removed. 
Circuit integrity was maintained until the pa-
tient was transported to the pediatric intensive 
care unit.
Perioperative Follow-up
For each patient, the following factors were 
evaluated before discharge and documented:
Hemodynamic parameters, perfusion and cross 
clamp duration, intubation period, postoperative 
hemorrhage, use of blood (as units) during the 
hospital stay, use of inotropic support, complica-
tions and infection, the duration of ICU stay and 
hospital stay, perioperative mortality.Comparison 
between groups was performed retrospectively. 
Blood Samples and Assays
Complete blood count [hemoglobin, hematocrit, 
erythrocyte, white blood cell (WBC) and platelet 
counts] was recorded. Results of standard blood 
and urine chemistry were documented. Blood sam-
ples were collected in potassium-EDTA (ethylene 
di-amine-tetra acetic acid) tubes using a radial or 
femoral artery catheter at the following intervals:
• Baseline: After induction of anesthesia (T1)
• OFF- CPB: 15 min. after reversal with protami-
ne (T2)
• ICU: 24 h postoperatively (T3)
Statistical Analysis 
Data was expressed as the mean ± the standard 
error of the mean. Analysis of variance for com-
parison of parameters with a normal distribution 
and Mann Whitney U test for comparison of pa-
rameters without normal distribution were used. 
Univariate analysis was performed on a large 
number of preoperative and intraoperative va-
riables in our database to identify those variables 
that might be associated with allogeneic blood 6 of 
the variables with a higher p-value were retained 
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for subsequent analysis.They were entered into a 
stepwise multiple logistic regression analysis to 
select the ones that were significant independent 
predictors of the need for transfusion. Data were 
analyzed using SPSS program (Inc. Chicago, IL, 
USA). p < 0.05 was considered statistically signi-
ficant.
Results
The time interval between birth and operati-
ve repair was not significantly different in both 
groups. There was not any significant difference 
with respect to age, gender, height, weight and 
body surface area between groups. 
Preoperative physical and laboratory evaluation 
revealed no difference among patient groups. List 
of variables that were screened for possible asso-
ciation with transfusion (dependent variable: tran-
sfused allogeneic blood) and significant predictors 
of allogeneic transfusions was listed in Table I. 
There was a significant decrease in transfusions 
when the program was started. The proportion of 
patients transfused with red blood cells was 75.2% 
(N=188) in control group and reduced by 16.4% in 
the study group (58.8% – 126 patients, p = 0.0089). 
The mean number of transfusions was 1.25 ± 0.5 
units per patient in control group and decreased 
to 0.7 ± 0.5 units per patient after the start of the 
program (p = 0.035).
Cerebral oximetry demonstrated significantly 
better follow-up during the operative period con-
firming less hemodilution in Group 1. Respiratory 
support duration, inotropic need and IUCU stay 
were significantly better in blood conservation 
group.Perioperative data is summarized in Table II. 
No mortality occurred in Group 1; however, 
two patients needed prolonged respiratory sup-
port for pneumonia and one required the im-
plantation of a permanent pacemaker. Mortality 
was two patients in Group 2 due to pulmonary 
hypertension. Moreover, two patients in this 
group needed prolonged respiratory support for 
pneumonia and one had a permanent pacemaker 
implanted.
Discussion
Blood administration is never without the risk 
for patients. As such, it is desirable to attempt 
to reduce or eliminate allogeneic blood product 
transfusions. More families and patients are be-
coming aware of the long and short-term risks as-
sociated with the administration of blood and are 
asking for bloodless techniques even if it is not a 
religious preference. 
Blood conservation has become popular fol-
lowing STS Guidelines but focused on adult car-
diac surgery. Ferraris et al12  on 2011 update noted 
the statement “for almost all topics reviewed only 
evidence relating to adult patients entered into the 
final recommendations, primarily because of limi-
ted availability of high quality evidence relating 
to pediatric patients having cardiac procedures”. 
Jonas13 later commented by underlining related 
studies on pediatric population. In 2008 Wypij et 
al14 published the combined results of 2 prospective 
randomized trials of hematocrit levels during CPB 
in infants. The authors concluded that a hematocrit 
level of approximately 24% or higher during CPB 
was associated with higher psychomotor develop-
ment index scores at 1 year of age and reduced 
lactate levels intraoperatively. Lower hematocrit 
levels were also associated with more positive in-
traoperative fluid balance. These 2 large National 
Institutes of Health–supported trials also demon-
strated that a goal hematocrit level of either 30% 
or 35% could be achieved during bypass without 
greater need for transfusion relative to the standard 
hematocrit level of 20% that was previously ap-
plied widely for pediatric CPB before these trials. 
Circuit miniaturization, ultrafiltration, and redu-
ced postoperative bleeding, presumably secondary 
to higher fibrinogen and other coagulation factor 
levels, contributed to this outcome14, 15. 
Table I. Significant Predictors of Alllogeneic Transfusions.
	 Odds	 Confidence	 Multıvarıate	
Rısk	factors	 Ratio	 interval	 p-value
Lower Body Surface Area 3.160 1.300-10.3 0.006
Lower Preoperative Hematocrit 4.3 1.300-9.500 0.003
Lower Red Blood Cell  Mass 1.1 0.950-0.970 0.056
Increased Total Crystalloid Volume 4.1 1.2-12.5 0.035
Conventional Circuit Size 5.8 1.190-20.540 0.021
Increased Postoperative bleeding in 24 h 3.7 1.250-9.150 0.005
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Ootaki et al16, in a prospective, non-continuous 
study of 75 pediatric patients undergoing cardiac 
surgery using a criteria-driven transfusion proto-
col, achieved 70% transfusion free procedures. 
Mean weight of the transfusion free group was 
24.6 ± 13.4 kg. 
We tried to implement a simple blood conser-
vation program including education, introduction 
of guidelines, follow-up of transfusions and re-
strictions on fluid balance. We made every pos-
sible effort intraoperatively by using CPB-related 
techniques to avoid hemodilution.
CPB exerts intended and unintended effects 
on the enzymatic and formed elements of the 
coagulation system. Compared with adults, 
children are at special risk for known, and 
unknown, differences in their hemostatic sy-
stems. Although children have relatively lar-
ger circulating blood volumes when compared 
with adults, their low absolute blood volume 
accentuates their dilutional coagulopathy. 
Further, their small blood volume creates 
practical limitations on the use of certain blo-
od conservation strategies such as autologous 
donation and cell saver17. 
Changes in oxygenator and CPB pump system 
design in the last 5 years and their introduction 
to the clinical arena have enabled significant re-
ductions in priming volume in pediatric bypass 
circuits. The pediatric population, excluding neo-
nates, provides the challenge of deciding whether a 
bloodless prime can be used for a specific patient.
One of the greatest benefits of the low prime 
condensed circuits is in the reduction of CPB pri-
me by eliminating an external arterial line filter 
and the associated filter bypass loop and extra tu-
bing needed to encompass the use of an arterial 
line filter. The elimination of an external arterial 
filter has not only reduced the overall CPB sur-
face area but has also allowed us to decrease our 
overall prime volumes. This has been accompli-
shed through a reduction in static prime volume 
and also by allowing placement of the oxygenator 
closer to the patient6. 
Our paper is a retrospective study and this is 
one of the main limitations of the data.We accept 
this data as preliminary to build a strategy and 
started a newer protocol and assessment based 
on current outcomes obtained from retrospective 
evaluation. 
In our series of blood conservation patients, 
we were able to achieve 41.2% of them (88/214) 
transfusion free procedures compared to 24.8 
(62/250) in control. 
We studied through variables related to preope-
rative and intraoperative period and demonstrated 
that the most significant risk factors for transfu-
sion were body surface area (OR: 3.16), preope-
rative hematocrit (OR: 4.3), red blood cell mass 
(OR: 1.1), total crystalloid volume (OR: 4.1), con-
ventional circuit (OR: 5.8), postoperative bleeding 
in 24 h (OR: 3.7). The results of the present study 
demonstrate that a structured blood conservation 
program reduces transfusion prevalence and this 
can be achieved without compromising patient 
safety.
The large variability in children, cardiac pa-
thology and surgical techniques has made large, 
randomized, clinical trials hard to conduct and 
difficult to analyze. Consequently, much practice 
has evolved from the application of animal data 
and shared experience. Currently, there is a lack 
of quality randomized, prospective clinical trials 
to support evidence-based practice. In order to 
Table II. Perioperative evaluation of patients.
 Group 1 Group 2
 (Blood Conservation) (Control) p
Duration of CPB (min) 120.4±56 122±39 =0.75
Duration of x-clamp (min) 84.4±26 92.2±27 =0.24
rSO2 desaturation risk>6000 (yes or no) (%) 15.8±9* 27.8±11 =0.038
t-intub (h) 11.4±7* 19.8±8 =0.041
Postop hemorrhage (mL) 145±50 175±55 =0.16
Blood transfusion (Unit) 0.7±0.5* 1.25±0.5 =0.035
Inotropic support (n) 69(32%)* 149(59.6%) =0.014
ICU stay (day) 3.2±1.1* 5.9±1.2 =0.045
Hospital stay (day) 10.4±3 15.5±4 =0.055
Mortality (n) - 2 =0.24
Tx: Transfusion; CPB: Cardiopulmonary bypass; X-clamp: Aortic cross clamp; t-intub: respiratory support time; ICU: Intensive 
care uni; rSO2: Regional cerebral O2 saturation
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continue to improve surgical outcomes, we must 
continue to ask the correct questions and attempt 
to answer them with the appropriate researches. 
Our patient population is small. That may be a 
reason not to get clear significant differences in 
most of the clinical parameters. 
Conclusions
We may say that there is incomplete evidence 
regarding to the transfusion decisions during pe-
diatric CPB. Our findings confirm that transfu-
sion of red blood cells during CPB may cause an 
undesirable clinical outcome. It is clear that blo-
od management with multiple strategies is valid 
for pediatric population. Hemodilution becomes 
more important in lower body surface area. We 
believe novel CPB technologies may be contri-
butory in blood management strategies regarding 
pediatric patients undergoing open-heart surgery. 
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